Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01153477 · ClinicalTrials.gov registry record · Phase 2
Effectiveness of Enhanced Treatments for Drug Dependence
A Phase 2 study of Cocaine Dependence, sponsored by University of Pennsylvania.
- Completed
- Registry status
- Phase 2
- Development phase
- 150
- Enrollment target
- 1
- Study location
NCT01153477: Completed Phase 2 study of Cocaine Dependence, sponsored by University of Pennsylvania.
NCT01153477 is a Phase 2 study of Cocaine Dependence that has completed, run by University of Pennsylvania. The registered enrollment target is 150 participants, below the 295-participant average among 38 other Cocaine Dependence trials with a reported enrollment target (49% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01153477, a Phase 2 study of Cocaine Dependence, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this challenge grant is to conduct an initial test of a new, enhanced version of this protocol (telephone monitoring and counseling - enhanced, or TMAC-E), which has been modified to include the elements of our existing continuing care intervention plus patient-centered changes to boost patient involvement and community linkages. The investigators will recruit 150 cocaine dependent patients in publicly funded, community-based programs and randomize them to treatment as usual or the TMAC-E and follow them for 12 months.
Primary Outcome
abstinence from drug and alcohol use within each 3 month period of the follow-up (as indicated by the TLFB)
Conditions Studied
Interventions
- BEHAVIORAL Telephone Monitoring and Counseling - Enhanced
Study Locations (1)
Pennsylvania
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2009-10 |
| Est. Completion | 2011-10 |
| Phase | Phase 2 |
What the finished NCT01153477 record still lists
NCT01153477 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 295-participant average among 38 other Cocaine Dependence trials with a reported enrollment target (49% lower).
The record links to 1 condition, with Cocaine Dependence appearing as the primary indexed condition, and to 1 intervention - of which Telephone Monitoring and Counseling - Enhanced is the first listed.
NCT01153477 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT01153477 about?
NCT01153477 is a clinical study titled "Effectiveness of Enhanced Treatments for Drug Dependence". The purpose of this challenge grant is to conduct an initial test of a new, enhanced version of this protocol (telephone monitoring and counseling - enhanced, or TMAC-E), which has been modified to include the elements of our existing continuing care intervention plus patient-centered changes to boo...
What is the current status of trial NCT01153477?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 150 participants. The study started on 2009-10. Estimated completion is 2011-10.
What conditions does trial NCT01153477 study?
This clinical trial studies the following conditions: Cocaine Dependence.
What interventions are being tested in trial NCT01153477?
The interventions under investigation include: Telephone Monitoring and Counseling - Enhanced (BEHAVIORAL).
Who is sponsoring clinical trial NCT01153477?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01153477 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cocaine Dependence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01153477's enrollment target sits among peer trials
150 11th of 38 higher than 27 of 38 other Cocaine Dependence trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cocaine Dependence trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Clavulanic Acid for the Treatment of Cocaine Use Disorder
ACTIVE NOT RECRUITING · Phase 2
-
Glutamatergic Modulation of Cocaine-related Deficits
COMPLETED · Phase 2
-
Disulfiram for Cocaine Abuse
COMPLETED · Phase 2
-
Multicenter Trial of Combined Pharmacotherapy to Treat Cocaine Dependence
COMPLETED · Phase 2
-
Citalopram for Cocaine Dependence
COMPLETED · Phase 2
-
PHASE IIA: Trial of a Novel Ondansetron Formulation (OND-PR002) and Immediate-Release Methylphenidate (Ritalin®)(OND003IND)
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia